SR One
SR One Capital Management is an American venture capital firm with offices in California, Pennsylvania and England.
History
In November 2020, SR One spun out from its parent company, GlaxoSmithKline.1)
Organization
SR One is part of the Kauffman Fellows network.2)
Portfolio
External links
1)
Al Idris, A. (2020, November 19). SR One breaks off from GlaxoSmithKline, banks $500M fund. Fierce Biotech. https://web.archive.org/web/20230513162017/https://www.fiercebiotech.com/biotech/sr-one-breaks-off-from-glaxosmithkline-banks-500m-fund
2)
Firm directory. Kauffman Fellows. Retrieved September 30, 2022, from https://web.archive.org/web/20220930161909/https://www.kauffmanfellows.org/firmdirectory
3)
Selected Portfolio. SR One Capital Management. Retrieved May 13, 2023, from https://web.archive.org/web/20230513155855/https://www.srone.com/portfolio
4)
Historical investments. SR One. Retrieved December 10, 2005, from https://web.archive.org/web/20051210023411/http://www.srone.com/portfolio/
5)
Series E - Aileron Therapeutics - 2014-10-29 - Crunchbase Funding Round Profile. Crunchbase. Retrieved May 11, 2023, from https://www.crunchbase.com/funding_round/aileron-therapeutics-series-e--740ce9be